venBio Select Advisor »

89bio shares owned by venBio Select Advisor

Quarter-by-quarter ownership of 89bio (ETNB) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in 89bio

Tip: Access up to 7 years of quarterly data

All positions including 89bio held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 89bio by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2025-09-30 $94M 6.4M 14.70
2025-06-30 $66M 6.8M 9.82
2025-03-31 $46M 6.4M 7.27
2024-12-31 $32M 4.1M 7.82

More positions owned by venBio Select Advisor

Ascendis Pharma Sponsored ADR (ASND)
United Therapeutics Corp Common (UTHR)
Madrigal Pharmaceuticals Common (MDGL)
Argenx Se Sponsored ADR (ARGX)
Krystal Biotech Common (KRYS)
Arrowhead Pharmaceuticals Common (ARWR)
Kymera Therapeutics Common (KYMR)
Merus N V Common (MRUS)
Avidity Biosciences Common (RNA)
Apellis Pharmaceuticals Common (APLS)
Centessa Pharmaceuticals Sponsored Adr (CNTA)
Uniqure Nv Common (QURE)
Xenon Pharmaceuticals Common (XENE)
Akero Therapeutics Common (AKRO)
Vera Therapeutics Common (VERA)

View all positions for venBio Select Advisor

Top funds holding 89bio

RA Capital Management
Pentwater Capital Management
BlackRock
Deep Track Capital
Adage Capital Partners GP
Suvretta Capital Management
Vanguard Group
venBio Select Advisor
Glazer Capital
Henderson Group
State Street Corporation
Deutsche Bank Aktiengesellschaft
Westfield Capital Management Company
Geode Capital Management
LMR Partners

View all funds holding 89bio